Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Item
http://www.wikidata.org/entity/Q37467237
Upregulation of mucin glycoprotein MUC1 in the progression to esophageal adenocarcinoma and therapeutic potential with a targeted photoactive antibody-drug conjugatePopulation pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer.MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models.MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potentialMUC1 immunotherapy is here to stay.MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy.Simple sugars to complex disease--mucin-type O-glycans in cancer.BRAF Mutations as Predictive Biomarker for Response to Anti-EGFR Monoclonal Antibodies.Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid Tumour.A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.Implication of Soluble Forms of Cell Adhesion Molecules in Infectious Disease and Tumor: Insights from Transgenic Animal Models.EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.Immunotherapy of breast cancer
P2860

Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Item
http://www.wikidata.org/entity/Q37467237
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I dose escalation pharma ...... s with advanced breast cancer.
@en
Phase I dose escalation pharma ...... s with advanced breast cancer.
@nl
type
label
Phase I dose escalation pharma ...... s with advanced breast cancer.
@en
Phase I dose escalation pharma ...... s with advanced breast cancer.
@nl
prefLabel
Phase I dose escalation pharma ...... s with advanced breast cancer.
@en
Phase I dose escalation pharma ...... s with advanced breast cancer.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Phase I dose escalation pharma ...... s with advanced breast cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P932